Insider buying last 90 days
No open-market insider purchases were filed for ATAI in the last 90 days.
From Form 4 filings, dated to when each was filed.
Every ATAI insider filing, plotted on the chart in Gekko.Open ATAI in Gekko
No recent trading data for ATAI. The last close Gekko holds is Sep 10, 2026, so the figures on this page may be out of date.
NASDAQ: ATAI
AtaiBeckley (ATAI) Stock Analysis & Forecast
Sep 10 close
$7.35+0.06 (+0.8%)
Gekko Brief
Sep 10 closeAtaiBeckley closed at $7.35 on 10 September 2026, +0.8% on the day. The price sits above both the 50-day ($6.85) and 200-day ($4.72) moving averages, inside a 52-week range of $3.27 to $7.45. The GekkoIndex reads 50.3, in the Neutral zone, down 0.3 points over five sessions. Gekko Fair Value is $8.12, so the price is 9.5% below it.
The next earnings report is due on 12 November 2026, 31 days away. Over the last 8 reports the company beat the earnings estimate 3 times, with an average move of 7.1% across the report. Seasonally, the next 20 trading days from this point averaged +1.7% over the last 5 years, rising in 2 of them.
12 firms rate the stock: 1 buy, 11 hold and 0 sell, with a consensus target of $8.12. A typical daily move is about 1.1%, and a typical 20-day move about 13.9%. On the swing-trade checklist, 3 items read supportive and 0 read as a headwind.
A plain summary of the figures as of the Sep 10, 2026 close.
AtaiBeckley price vs fair value
Close $7.35200-day averageGekko Fair Value $8.12
AtaiBeckley quick facts
- Market cap
- $2.72B
- P/E ratio
- —
- Forward P/E
- —
- EPS, TTM
- −$2.79
- Revenue, TTM
- $4.47M
- Profit margin
- 0%
- Dividend yield
- 0.00%
- Beta
- 1.55
- Volume
- 9.59M avg 13.79M
- 1-year return
- +50.3%
- Typical daily move
- ±1.1%
- Typical 20-day move
- ±13.9%
- 50-day average
- $6.85
- 200-day average
- $4.72
- Next earnings
- Nov 12
- Shares outstanding
- 370.9M
AtaiBeckley swing-trade checklist
AtaiBeckley scores 3 supportive, 2 mixed and 0 headwinds across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive2 mixed0 headwinds
- Trendsupportive
Above 50 and 200-day
Close $7.35 is above the 50-day ($6.85) and 200-day ($4.72) averages, and the 50-day is above the 200-day.
See the chart - GekkoIndexmixed
50.3, Neutral
Reading 50.3 is in the Neutral zone.
See the GekkoIndex - Fair valuesupportive
9.5% below
Price is 9.5% below Gekko Fair Value (more than 5% below).
See fair value - Smart moneyno data
No data
No insider, Congress or unusual options activity in the window.
See smart money - Earnings risksupportive
Reports in 31 days
Next report Nov 12, 2026, 31 days away — outside a typical 20-trading-day hold.
See earnings - Seasonalitymixed
+1.7% on average
From this point in the calendar, the next 20 trading days averaged +1.7% over 5 years, rising in 2 of them.
See seasonality
A description of current data, not a recommendation. How this page works
AtaiBeckley stock chart and price history
AtaiBeckley closed at $7.35 on Sep 10, 2026, +50.3% over the past year, inside a 52-week range of $3.27 to $7.45.
Close50-day average200-day averageVolume
Use the left and right arrow keys to read daily values.
Performance Breakdown
- 1 month
- +1.9%
- 3 months
- +94.4%
- 6 months
- +81.0%
- 1 year
- +50.3%
The full ATAI chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open ATAI in Gekko
Follow AtaiBeckley through every session
Put ATAI on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Track ATAI in GekkoFree for 7 days. No credit card required.
About AtaiBeckley
AtaiBeckley works as a clinical-stage biopharmaceutical company focused on finding, developing, and eventually bringing to market treatments for mental health conditions. Its pipeline spans several experimental compounds, including an intranasal formulation being tested for treatment-resistant depression and alcohol use disorder, an oral neuromodulator studied for cognitive impairment tied to schizophrenia, and other candidates targeting major depressive disorder, social anxiety disorder, and related conditions through various stages of clinical trials. The company is also known for its work with psilocybin-based and anxiety-focused therapeutic programs.
The company runs its research and trial programs across the United States, Germany, and Canada, reflecting a multi-country approach to developing its drug candidates. Its various compounds are each at different points in the clinical trial process, ranging from early to later-stage studies, as the firm works toward potential approval and commercialization of treatments for depression, anxiety, schizophrenia-related cognitive issues, and other neurological and psychiatric conditions.
AtaiBeckley is headquartered in New York, New York, and traces its founding to 2018, originally operating under the name Atai Beckley N.V. before adopting its current name in December 2025. Its shares are listed on the NASDAQ under the ticker ATAI.
- Listed
- NASDAQ
- Sector
- Health technology
- Industry
- Pharmaceuticals: major
- Website
- ataibeckley.com
AtaiBeckley GekkoIndex: the smart money zone
AtaiBeckley’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 50.3, in the Neutral zone, down 0.3 points over five sessions.
50.3Neutral
Down 0.3 points over five sessions.
Reading for Sep 10, 2026
What followed past readings in each zone
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 10 | +1.0% | +1.1% | ||
| Accumulation | 239 | +2.5% | +7.0% | ||
| Neutral (current zone) | 349 | +1.9% | +7.9% | ||
| Distribution | 60 | −1.7% | +3.1% | ||
| Selling | 3 | Too few readings yet | |||
Average ATAI share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
See every daily GekkoIndex reading plotted over the ATAI price, zone by zone.Track ATAI in Gekko
Is AtaiBeckley stock overvalued? Gekko Fair Value
AtaiBeckley trades 9.5% below Gekko Fair Value of $8.12, so the shares are undervalued on Gekko’s estimate.
Gekko’s own estimate of what AtaiBeckley shares are worth, recalculated every trading day.
$8.12
Gekko Fair Value, Sep 19, 2026
9.5% Undervalued
Gekko Fair Value on every chart, with the gap to price updating daily.Open ATAI in Gekko
AtaiBeckley insider and Congress trading
No open-market insider purchases were filed for AtaiBeckley, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
Congress trades last 90 days
No trades in ATAI were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Congress disclosures for ATAI, plotted on the chart in Gekko.Open ATAI in Gekko
Buybacks
AtaiBeckley has been buying back its own shares.
- Bought back, quarter ended Sep 30, 2025
- $3.56M
- As a share of market cap
- 0.13%
From company filings.
AtaiBeckley earnings: next date and track record
AtaiBeckley reports on Nov 12, 2026 (31 days away), and beat the EPS estimate in 3 of its last 8 reports.
Next earnings report
Nov 12, 2026
31 days away
- EPS estimate
- −$0.12
- Revenue estimate
- $400K
3 of 8reports beat the EPS estimate
±7.1%average move across the report
3 of 8reports followed by a gain
Share-price move across each report
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 11, 2026 | −$0.09 est −$0.11 | $900K est $430K | −0.3% |
| May 12, 2026 | −$0.08 est −$0.10 | $954K est $217K | +5.0% |
| Mar 6, 2026 | −$1.73 est −$0.10 | $1.07M est $300K | +9.9% |
| Nov 12, 2025 | −$0.28 est −$0.12 | $749K est $229K | −6.8% |
| Aug 14, 2025 | −$0.14 est −$0.12 | $719K | −4.2% |
| May 14, 2025 | −$0.15 est −$0.18 | $1.56M | +15.6% |
| Mar 17, 2025 | −$0.24 est −$0.15 | −$5K est $300K | −8.8% |
| Nov 13, 2024 | −$0.16 est −$0.16 | $40K est $250K | −6.2% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
AtaiBeckley stock forecast and analyst price targets
Analysts’ average 12-month price target for AtaiBeckley is $8.12, +10.5% from the last close, from 12 firms rating the stock in the last 90 days.
$8.12consensus 12-month target, +10.5% from the last close
Now $7.35Avg $8.12
Low $7.45High $8
Each firm’s latest rating in the last 90 days: 12 firms.
Latest analyst actions
| Date | Firm | Target | vs price |
|---|---|---|---|
| Aug 19 | H.C. Wainwright | $7.50 | +2.0% |
| Aug 17 | Oppenheimer | — | — |
| Aug 12 | Deutsche Bank | $8 | +8.8% |
| Jul 20 | Berenberg Bank | $7.45 | +1.4% |
| Jul 20 | H.C. Wainwright | $7.50 | +2.0% |
+7.9%average 20-day move after past Neutral readings
+1.7%average move over the next 20 trading days in the last 5 years
±1.1%typical daily move, from the 14-day average range
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
AtaiBeckley seasonality: the next 20 trading days
Over the next 20 trading days from Oct 10, AtaiBeckley averaged +1.7% across the last 5 years, rising in 2 of them.
Next 20 trading days, by year
Average move and hit rate
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +6.7% | 3 of 5 |
| Next 10 trading days | +2.6% | 3 of 5 |
| Next 15 trading days | +3.8% | 3 of 5 |
| Next 20 trading days | +1.7% | 2 of 5 |
| Next 30 trading days | −5.3% | 1 of 5 |
For scale, ATAI’s typical 20-trading-day move in either direction is about 13.9%.
AtaiBeckley market cap and key statistics
AtaiBeckley’s market cap is $2.72B and revenue of $4.47M over the last twelve months.
Valuation
- Market cap
- $2.72B
- EPS, TTM
- −$2.79
- Gekko Fair Value
- $8.12
Trading
- Volume
- 9.59M
- Avg volume, 20 days
- 13.79M
- 52-week high
- $7.45
- 52-week low
- $3.27
- Shares outstanding
- 370.9M
Financials
- Revenue, TTM
- $4.47M
- Profit margin
- 0%
- Return on equity
- -417.2%
- Quarterly earnings growth, YoY
- −96.8%
Risk and income
- Beta
- 1.55
- Typical daily move
- ±1.1%
- Typical 20-day move
- ±13.9%
- Dividend yield
- 0.00%
AtaiBeckley stock news this week
1 headline about AtaiBeckley from the past week, newest first, each linking to the publisher.
- Why Is AtaiBeckley Inc (ATAI) Up 0.8% Since Last Earnings Report?Zacks Investment Research, Sep 10
AtaiBeckley peers
AtaiBeckley’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| LLYEli Lilly | Neutral | 14.7% above |
| JNJJohnson & Johnson | Neutral | 3.2% below |
| ABBVAbbVie | Distribution | 28.2% above |
| MRKMerck | Neutral | 8.0% below |
| AZNAstraZeneca | Accumulation | 41.7% below |
| PFEPfizer | Neutral | 8.0% below |
A peer links to its own page where one exists.
AtaiBeckley stock FAQ
What is AtaiBeckley’s market cap?
AtaiBeckley’s market cap is $2.72B at the Sep 10, 2026 close of $7.35, with 370.9M shares outstanding.
What is the AtaiBeckley stock forecast?
The consensus analyst 12-month price target for AtaiBeckley is $8.12, +10.5% from the last close. Of the 12 firms that rated the stock in the last 90 days, 1 rate it a buy, 11 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
Is AtaiBeckley stock overvalued or undervalued?
On Gekko’s estimate AtaiBeckley is undervalued: the Sep 10, 2026 close of $7.35 is 9.5% below Gekko Fair Value of $8.12. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
When does AtaiBeckley report earnings next?
AtaiBeckley is expected to report on Nov 12, 2026 (31 days away). Analysts expect earnings of −$0.12 per share on revenue of $400K. AtaiBeckley beat the earnings estimate in 3 of its last 8 reports, moving 7.1% on average across the report.
What is AtaiBeckley’s 52-week high and low?
AtaiBeckley’s 52-week high is $7.45 and its 52-week low is $3.27; it closed at $7.35 on Sep 10, 2026, +50.3% over the past year. Over the last five years the shares peaked at $17.81 on Nov 3, 2021.
Is AtaiBeckley stock a buy right now?
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (trend, fair value and earnings risk), 2 as mixed (gekkoindex and seasonality). The checklist is a description of current data, not a recommendation.
How this page works
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
See AtaiBeckley the way Gekko members do
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,408 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.